Sponsor:
Mersana Therapeutics
Code:
NCT05377996
Conditions
Triple Negative Breast Cancer
Breast Cancer
Endometrial Cancer
Ovarian Cancer
Fallopian Tube Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
XMT-1660
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-10. This information was provided to ClinicalTrials.gov by Mersana Therapeutics on 2025-09-26.